3 No-Brainer Growth Stocks to Buy in December
's "Just Do It" tagline usually isn't great advice for investors. It's smart to conduct solid research on a stock before buying. That said, some outliers are so promising that spending a lot of time in analysis isn't so necessary.
Three Motley Fool contributors believe they've identified such exceptions. Here's why they think Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Vertex Pharmaceuticals (NASDAQ: VRTX) are no-brainer growth stocks to buy in December.
David Jagielski (Eli Lilly): Eli Lilly is becoming a beast in the healthcare industry. Its market cap is up to $560 billion, and the stock trades at more than 100 times its trailing earnings. Yet, despite such an astronomical valuation, this is a no-brainer investment.
Source Fool.com
Nike Inc. B Aktie
Die Nike Inc. B Aktie zieht viel Aufmerksamkeit auf sich: Viel mehr Buy- als Sell-Einschätzungen.
Die Community erwartet für Nike Inc. B ein Kursziel von 110 €, was eine deutliche Steigerung von über 20% gegenüber dem aktuellen Kurs von 75.09 € bedeuten könnte.
